Does Nektar Therapeutics (NKTR) Stock Really Excited You?
JP Morgan raised the price target for the Nektar Therapeutics (NASDAQ:NKTR) stock to “an Underweight”. The rating was released on November 20, 2023, according to finviz. The research report from Jefferies has upgraded the stock from Underperform to Hold, with a price target set at $1. The stock was downgraded by Jefferies, who disclosed in […]
Is Nektar Therapeutics (NKTR) Stock a good investment?
JP Morgan raised the price target for the Nektar Therapeutics (NASDAQ:NKTR) stock to “an Underweight”. The rating was released on November 20, 2023, according to finviz. The research report from Jefferies has upgraded the stock from Underperform to Hold, with a price target set at $1. The stock was downgraded by Jefferies, who disclosed in […]
What does Nektar Therapeutics (NKTR) Stock have to offer?
JP Morgan raised the price target for the Nektar Therapeutics (NASDAQ:NKTR) stock to “an Underweight”. The rating was released on November 20, 2023, according to finviz. The research report from Jefferies has upgraded the stock from Underperform to Hold, with a price target set at $1. The stock was downgraded by Jefferies, who disclosed in […]
Is it possible to sustain this rally? Nektar Therapeutics (NKTR) Stock
JP Morgan raised the price target for the Nektar Therapeutics (NASDAQ:NKTR) stock to “an Underweight”. The rating was released on November 20, 2023, according to finviz. The research report from Jefferies has upgraded the stock from Underperform to Hold, with a price target set at $1. The stock was downgraded by Jefferies, who disclosed in […]
Recent trade makes Nektar Therapeutics (NKTR) Stock an appealing buy
JP Morgan raised the price target for the Nektar Therapeutics (NASDAQ:NKTR) stock to “an Underweight”. The rating was released on November 20, 2023, according to finviz. The research report from Jefferies has upgraded the stock from Underperform to Hold, with a price target set at $1. The stock was downgraded by Jefferies, who disclosed in […]
Why Nektar Therapeutics (NASDAQ:NKTR) Stock climbed 92.52% in Last Three Months?
JP Morgan raised the price target for the Nektar Therapeutics (NASDAQ:NKTR) stock to “an Underweight”. The rating was released on November 20, 2023, according to finviz. The research report from Jefferies has upgraded the stock from Underperform to Hold, with a price target set at $1. The stock was downgraded by Jefferies, who disclosed in […]
Is it possible to sustain this rally? Nektar Therapeutics (NKTR) Stock
JP Morgan raised the price target for the Nektar Therapeutics (NASDAQ:NKTR) stock to “an Underweight”. The rating was released on November 20, 2023, according to finviz. The research report from Jefferies has upgraded the stock from Underperform to Hold, with a price target set at $1. The stock was downgraded by Jefferies, who disclosed in […]
Nektar Therapeutics (NASDAQ:NKTR) stock Posted Gross Margin of 62.53 percent in Last Year: Is Justifiable?
JP Morgan raised the price target for the Nektar Therapeutics (NASDAQ:NKTR) stock to “an Underweight”. The rating was released on November 20, 2023, according to finviz. The research report from Jefferies has upgraded the stock from Underperform to Hold, with a price target set at $1. The stock was downgraded by Jefferies, who disclosed in […]
